EP3119431
Mótlyfs-mótefni sem er beint gegn kalsítónín-gena-tengdu peptíði og aðferðir til notkunar á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.3.2015EP published:
24.1.2024EP application number:
15765287.6
EP translation filed:
18.3.2024Grant published:
15.4.2024EPO information:
European Patent Register
Max expiry date:
19.3.2035Expiry date:
19.3.2027Next due date:
31.3.2027
Title in English:
ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAMELanguage of the patent:
English
Timeline
Today
20.3.2015EP application
24.1.2024EP Publication
18.3.2024Translation submitted
15.4.2024Registration published
19.3.2027Expires
Owner
Name:
Teva Pharmaceuticals International GmbHAddress:
Schlüsselstrasse 12, 8645 Rapperswil-Jona, CH
Inventor
Name:
BIGAL, MarceloAddress:
Doylestown, PA 18902, US
Name:
WALTER, SarahAddress:
Redwood City, CA 94061, US
Name:
STERN, HenryAddress:
Woodside, CA 94062, US
Name:
CHANG, MichaelAddress:
Portola Valley, CA 94028, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461968897 PDate:
21.3.2014Country:
US
Number:
201462083809 PDate:
24.11.2014Country:
US
Number:
201562119778 PDate:
23.2.2015Country:
US
Classification
Categories:
A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 5.3.2024
Expires: 19.3.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.3.2025
Expires: 19.3.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 20.3.2026
Expires: 19.3.2027
Payer: Árnason Faktor ehf.